Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
type
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

818607

	registered interest
	date	08/01/2018
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mefloquine
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government, further to the Written Answer by Lord O'Shaughnessy on 22 December 2017 (HL4314), whether they consider suicide, as listed in the current mefloquine product information as a psychiatric adverse reaction, to be a permanent adverse reaction.
	tabling member printed	The Countess of Mar
	type	WrittenParliamentaryQuestion
	uin	HL4484
	answer	answer is ministerial correction date of answer 18/01/2018 answer text <p>Feeling suicidal, or the risk of suicide, would not be considered to be permanent adverse reactions.</p><p>Mefloquine is effective in the prevention and treatment of malaria and is approved by the Medicines and Healthcare products Regulatory Agency (MHRA), which regulates medication in the United Kingdom. As with all medicines, the MHRA keeps the safety of mefloquine under continual review. Mefloquine continues to be recommended as a safe and effective form of malaria prevention by the Advisory Committee on Malaria Prevention, the World Health Organization and other respected organisations who take account of the body of global evidence.</p> answering member printed Lord O'Shaughnessy question first answered 18/01/2018 12:23:37 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	1861 label Biography information for The Countess of Mar

818610

	registered interest
	date	08/01/2018
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Levonorgestrel: Prices
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether they intend to investigate the pricing of levonorgestrel by pharmacies.
	tabling member printed	Lord Myners
	type	WrittenParliamentaryQuestion
	uin	HL4487
	answer	answer is ministerial correction date of answer 18/01/2018 answer text <p>The Department does not control prices of medicines sold at pharmacies without a prescription. Emergency hormonal contraception is however available free of charge on the National Health Service.</p> answering member printed Lord O'Shaughnessy question first answered 18/01/2018 12:22:42 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3869 label Biography information for Lord Myners

818651

	registered interest
	date	08/01/2018
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Innovative Medicines and Medical Technology Review
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the Government response to the Accelerated Access Review published in November 2017, what plans his Department has to streamline existing routes to market for medical technologies, devices and diagnostics.
	tabling member constituency	East Kilbride, Strathaven and Lesmahagow
	tabling member printed	Dr Lisa Cameron
	type	WrittenParliamentaryQuestion
	uin	121415
	answer	answer is ministerial correction date of answer 16/01/2018 answer text <p>We are introducing a new Accelerated Access Pathway, to streamline regulatory and market access decisions, getting breakthrough products that we believe will be truly transformative to patients more quickly. A new Accelerated Access Collaborative (AAC) chaired by Sir Andrew Witty, will develop and own the Accelerated Access Pathway which will be operational from April 2018. All products including medical technologies, devices and diagnostics will be eligible for selection. In addition to the new Pathway, the AAC will also make recommendations to the Government and its partners about opportunities to further streamline existing routes to market.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 16/01/2018 12:04:46 answering member 4067 label Biography information for Steve Brine
	tabling member	4412 label Biography information for Dr Lisa Cameron

818752

	registered interest
	date	08/01/2018
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Coperforma
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what information his Department holds on how much was paid by NHS bodies to cover private sector liabilities to workers as a result of the performance problems with Patient Transport Services provided by Coperforma; how much money has been recovered to the public purse from Coperforma as a result of those performance problems; whether outstanding liabilities relating to that Coperforma contract will be recovered following the liquidation of Coperforma Ltd; and if he will make a statement.
	tabling member constituency	Brighton, Pavilion
	tabling member printed	Caroline Lucas
	type	WrittenParliamentaryQuestion
	uin	121516
	answer	answer is ministerial correction date of answer 16/01/2018 answer text <p>The information requested is not collected centrally.</p><p>The provision of patient transport services is a matter for local National Health Service commissioners. NHS England has advised that High Weald Havens Clinical Commissioning Group commissioned an independent investigation into these events, which reported in March 2017. Accordingly, there are no plans to undertake a further independent investigation.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 121517 121520 question first answered 16/01/2018 16:19:44 answering member 4067 label Biography information for Steve Brine
	tabling member	3930 label Biography information for Caroline Lucas

818753

	registered interest
	date	08/01/2018
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Coperforma
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will commission a formal, independent investigation into the outsourcing and performance problems of the Patient Transport Services provided by Coperforma and arms length driver operatives, including an assessment of monies paid to Coperforma and monies paid by the public sector as a result of Coperforma's performance failures; and if he will make a statement.
	tabling member constituency	Brighton, Pavilion
	tabling member printed	Caroline Lucas
	type	WrittenParliamentaryQuestion
	uin	121517
	answer	answer is ministerial correction date of answer 16/01/2018 answer text <p>The information requested is not collected centrally.</p><p>The provision of patient transport services is a matter for local National Health Service commissioners. NHS England has advised that High Weald Havens Clinical Commissioning Group commissioned an independent investigation into these events, which reported in March 2017. Accordingly, there are no plans to undertake a further independent investigation.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 121516 121520 question first answered 16/01/2018 16:19:44 answering member 4067 label Biography information for Steve Brine
	tabling member	3930 label Biography information for Caroline Lucas

818756

	registered interest
	date	08/01/2018
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	High Weald Lewes Havens Clinical Commissioning Group
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the Answer of 8 November 2016 to Question 51429, if he will publish a copy of the validated analysis of costs provided by Coperforma Ltd to the High Weald Havens Clinical Commissioning Group referred to in that Answer; what the value is of invoices the High Weald Havens Clinical Commissioning Group received directly from each trust which incurred private ambulance costs arising from performance problems with Patient Transport Services provided by Coperforma and arms length driver operatives; and if he will make a statement.
	tabling member constituency	Brighton, Pavilion
	tabling member printed	Caroline Lucas
	type	WrittenParliamentaryQuestion
	uin	121520
	answer	answer is ministerial correction date of answer 16/01/2018 answer text <p>The information requested is not collected centrally.</p><p>The provision of patient transport services is a matter for local National Health Service commissioners. NHS England has advised that High Weald Havens Clinical Commissioning Group commissioned an independent investigation into these events, which reported in March 2017. Accordingly, there are no plans to undertake a further independent investigation.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 121516 121517 question first answered 16/01/2018 16:19:44 answering member 4067 label Biography information for Steve Brine
	tabling member	3930 label Biography information for Caroline Lucas

818827

	registered interest
	date	08/01/2018
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hospital Beds
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what information his Department holds on the number of hospital beds there are per one thousand of the population in (a) England, (b) Wales, (c) Scotland and (d) Northern Ireland.
	tabling member constituency	Cynon Valley
	tabling member printed	Ann Clwyd
	type	WrittenParliamentaryQuestion
	uin	121591
	answer	answer is ministerial correction date of answer 16/01/2018 answer text <p>The information is not available in the format requested.</p><p> </p><p>NHS England publishes quarterly data on hospital bed availability and occupancy. This can be found at:</p><p> </p><p><a href="https://www.england.nhs.uk/statistics/statistical-work-areas/bed-availability-and-occupancy/" target="_blank">https://www.england.nhs.uk/statistics/statistical-work-areas/bed-availability-and-occupancy/</a></p><p> </p><p>Health is a devolved matter which means the devolved administrations of Wales, Scotland and Northern Ireland determine their own methods for capturing and publishing data on their number of hospital beds.</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 16/01/2018 12:09:09 answering member 4095 label Biography information for Steve Barclay
	tabling member	553 label Biography information for Ann Clwyd

818845

	registered interest
	date	08/01/2018
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mental Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what guidelines his Department issues to people with mental health conditions with financial difficulties on accessing specialised support services.
	tabling member constituency	East Kilbride, Strathaven and Lesmahagow
	tabling member printed	Dr Lisa Cameron
	type	WrittenParliamentaryQuestion
	uin	121609
	answer	answer is ministerial correction date of answer 16/01/2018 answer text <p>The Department does not issue guidelines on accessing specialised support services for people with mental health conditions who may be experiencing financial difficulties. Where financial difficulties are identified as an issue for a person receiving treatment and care for a mental health condition, signposting already exists in some general practitioner (GP) practices and in Improving Access to Psychological Therapies services.</p><p>A person who is experiencing financial difficulties or a debt crisis may approach their GP or another health professional to provide evidence of their mental health condition to their creditors to help aid any support a creditor may be able to provide to that person. The Government is currently reviewing the process for GPs and other health professionals completing Mental Health Evidence Forms to support this process.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 16/01/2018 12:27:21 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4412 label Biography information for Dr Lisa Cameron